DHS WisdomTree U.S. High Dividend Fund
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| XOM | 5.92% |
| MO | 5.01% |
| ABBV | 4.62% |
| PM | 4.15% |
| MRK | 4.01% |
| CVX | 3.98% |
| T | 3.53% |
| PEP | 3.50% |
| VZ | 3.05% |
| BMY | 2.51% |
ETF Analysis
Fund Overview
WisdomTree U.S. High Dividend Fund (DHS) currently reports 317 stock positions (subject to change), placing it in the widely diversified range by holdings breadth. The top line-up is XOM (5.92%), MO (5.01%), ABBV (4.62%), with XOM as the largest single weight at 5.92%. Together, the top three holdings account for 15.55%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 16.10%, WACC is 6.14%, and the economic spread is 9.96%. On balance, the economic spread is positive but compressed — adequate for value preservation, less convincing for aggressive compounding. Supporting metrics show ROE at 20.46% and ROA at 7.77%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.
Valuation
On valuation, the portfolio registers trailing P/E of 16.58, forward P/E of 13.23, PEG of 1.98. The minimal trailing-to-forward compression implies limited earnings growth expectations are embedded in current prices. The PEG reading here implies the market is pricing growth at roughly fair value — a setup where the investment case depends more on execution than on multiple expansion. A current ratio of 2.90 across the holding set reflects strong short-term liquidity. Taken together, the multiple and liquidity picture suggests a portfolio that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 54.11%, operating margin at 28.02%, and free cash flow margin at 19.31%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. At this FCF margin level, the underlying holdings demonstrate good cash generation relative to the revenue base. Together, these margin readings describe a portfolio of businesses that protect profitability at every layer of the income statement.
Growth & Forward Outlook
Connecting operational trends with market expectations, TTM revenue growth of 12.11% indicating steady top-line growth at the portfolio level, while the estimated 12-month price change of 9.14%, where consensus projections imply only modest price appreciation from current levels. At 25.4%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyOverall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.